Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 602670
                    [Title] => CEO reaffirms Invida's commitment to RP
                    [Summary] => 
When a startup San Francisco-based biotechnology company went public in October 1980, raising $35 million after less than an hour on NASDAQ, an enterprising biochemistry student in London followed that initial day of trading with enthusiastic admiration.
                    [DatePublished] => 2010-08-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Lifestyle Business
                    [SectionUrl] => business-life
                    [URL] => 
                )

        )

)

INVIDA GROUP

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 602670
                    [Title] => CEO reaffirms Invida's commitment to RP
                    [Summary] => 
When a startup San Francisco-based biotechnology company went public in October 1980, raising $35 million after less than an hour on NASDAQ, an enterprising biochemistry student in London followed that initial day of trading with enthusiastic admiration.
                    [DatePublished] => 2010-08-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Lifestyle Business
                    [SectionUrl] => business-life
                    [URL] => 
                )

        )

)

abtest

CEO reaffirms Invida's commitment to RP

August 16, 2010 - 12:00am

When a startup San Francisco-based biotechnology company went public in October 1980, raising $35 million after less than an hour on NASDAQ, an enterprising biochemistry student in London followed that initial day...

Lifestyle Business